drugset / Trial / NCT00437255

Efficacy, Safety, Preference and Response Duration of Clobex® Spray and Taclonex® Ointment in Psoriasis

NCT00437255

Phase 4 Completed 122 enrolled Galderma R&D
RandomizedParallel-groupSingle-blindTreatment

Summary

Evaluate the efficacy of Clobex® Spray as compared to Taclonex® Ointment in terms of Overall Disease Severity and Investigator Global Assessment.

Timeline

Start
2006-08
Primary completion
2007-06
Completion
2007-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Calcipotriol Small molecule Topical
Comparator betamethasone dipropionate Small molecule Topical
Comparator clobetasol propionate Small molecule 0.05 % Topical

Indications